The 85th Annual Meeting of the Japanese Cancer Association

JCA Young Investigator Poster Award – Results Announcement

Among the abstracts submitted to the 85th Annual Meeting of the Japanese Cancer Association with young researchers as first authors and presenters, the presentations were evaluated based on their content delivered during the meeting.

We are pleased to announce that the following presentations have been selected for the JCA Young Investigator Poster Award.

JCA Young Investigator Poster Award – Winning Presentations

Congratulations to all the award winners!

P-1052

Qin FanDept. Mol. Oncol., Grad. Sch. Med., Ch

Functional dissection of SOX9 super enhancers reveals TCF7L2-dependent regulation in EBV-positive gastric cancer

P-1090

Shiho FujiokaDiv. of Cell Signaling & Mol. Med. IMSUT

Enhanced SAPK pathway sensitivity promotes colitis-associated tumorigenesis in mice.

P-1242

Yutaka NoguchiDiv. Mol. Pharmacology, Cancer Chemother. Ctr., JFCR

PI3K inhibitors inhibit the interaction between FUS::DDIT3 and the BAF complex, thereby inducing apoptosis in MLS

P-1265

Yi-Che WuInstitute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan

KRT6A promotes anti-PD-1 resistance via collagen remodeling in head and neck squamous cell carcinoma

P-1352

Yo KimuraDivision of Cellular Signaling, National Cancer Center Research Institute

Spatial Transcriptomic Analysis of Giant Cell-Tumor Cell Interactions in Giant Cell Tumor of Bone

P-1353

Takeo SuzukiDivision of Cellular Signaling, National Cancer Center Research Institute

Single-cell and Spatial Analysis of Tumor State Transition and Microenvironmental Remodeling in MPNST Progression

P-2059

Ryo AraiDpt of Mol Oncology, Grad Sch of Med, Chiba Univ

Identification of LEF1-mediated activation of Wnt signaling in maxillary sinus carcinoma by integrated omics analyses

P-2065

Chia Wei ChouDepartment of Life Science, National Taiwan Normal University, Taipei, Taiwan

STING-SPZ1 Perpetuating Loop Reprograms Macrophage Polarization to Potentiate IFN-γ Immunotherapy in Lung Tumor

P-2076

Yi H. HSUDepartment of Life Science, National Taiwan Normal University, Taipei, Taiwan

Dysregulated hepatic ISX-RXR alpha axis provokes lipogenesis, metabolic remodeling and steatohepatitis microenvironment

P-2082

Naoya KobayashiLab. Fundamental Oncol., Natl. Cancer Ctr. Res. Inst., Tokyo

Oncogenic Reprogramming of a p53 Target: PHLDA3 Activates YAP to Drive Liver Cancer.

P-2130

Hirokazu KusunokiDiv. of Cancer Cell Biol., Cancer Research Institute, Kanazawa Univ.

Mitochondrial one-carbon metabolic enzyme MTHFD1L contributes to breast cancer tumorigenesis and lung metastasis

P-2141

Shin SuzukiDept Prev. Med., Grad. School. Med., The Univ. Tokyo

Single-cell spatial multi-omics analysis reveals the tumor microenvironment of metastatic niches in gastric cancer

P-2173

Tomomi NamikiDepartment of Preventive Medicine, The University of Tokyo

Spatial and Clonal Dynamics of B Cells in Cancer Tissue Revealed by Integrated BCR and Transcriptomic Profiling

P-2199

Yu IshiiLab Immunogenomics, Natl Inst Biomed Innovation, Health and Nutrition (NIBN)

Development of new immunotherapies targeting pancreatic cancer

P-3069

Yasuyoshi MiyachiGrad. Sch. of Front. Sci., Univ. Tokyo

Identifying novel molecular events associated with HGNEC progression using ultra-long read sequencing technology

P-3126

Motochika HamadaDivision of Drug Development, EPOC, National Cancer Center

IL-7R-LYN Axis Orchestrates a Stepwise Program of Brain-Directed Infiltration in Acute Lymphoblastic Leukemia

P-3173

Hiromu KawanoDept. of Respiratory Med., Grad. Sch. of Med., Kyushu Univ.

Evaluation of Tumor-TME Interactions in EGFR-Mutant Tumors with TP53 GOF under Osimertinib treatment.

P-3200

Takanori KondoDepartment of Respiratory Medicine and Hematology, Hyogo Medical University

Galectin-9-targeted therapy for aiming cure in oncogenic driver alterations-positive non-small cell lung cancer

P-3220

Xin LuDepartment of Tumor Pathology Nagoya University Graduate School of Medicine

Study on the effect of fibroblast reprogramming on the efficacy of K-Ras inhibitors in cancer mouse models

P-3257

Koki FujiiDept. of Respiratory Med., The Univ. of Tokyo

Target-Enhanced Whole-Genome Sequencing of FFPE Samples in Lung Cancer: Comparison with Comprehensive Genomic Profiling